118 related articles for article (PubMed ID: 16935940)
1. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme.
Hershfield JR; Madhavarao CN; Moffett JR; Benjamins JA; Garbern JY; Namboodiri A
FASEB J; 2006 Oct; 20(12):2139-41. PubMed ID: 16935940
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of aspartoacylase in the rat central nervous system.
Madhavarao CN; Moffett JR; Moore RA; Viola RE; Namboodiri MA; Jacobowitz DM
J Comp Neurol; 2004 May; 472(3):318-29. PubMed ID: 15065127
[TBL] [Abstract][Full Text] [Related]
3. Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease.
McPhee SW; Francis J; Janson CG; Serikawa T; Hyland K; Ong EO; Raghavan SS; Freese A; Leone P
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):112-21. PubMed ID: 15857674
[TBL] [Abstract][Full Text] [Related]
4. Endogenous aspartoacylase expression is responsive to glutamatergic activity in vitro and in vivo.
Francis JS; Strande L; Pu A; Leone P
Glia; 2011 Oct; 59(10):1435-46. PubMed ID: 21608034
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease.
Matalon R; Surendran S; Rady PL; Quast MJ; Campbell GA; Matalon KM; Tyring SK; Wei J; Peden CS; Ezell EL; Muzyczka N; Mandel RJ
Mol Ther; 2003 May; 7(5 Pt 1):580-7. PubMed ID: 12718900
[TBL] [Abstract][Full Text] [Related]
6. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
[TBL] [Abstract][Full Text] [Related]
7. Extensive aspartoacylase expression in the rat central nervous system.
Moffett JR; Arun P; Ariyannur PS; Garbern JY; Jacobowitz DM; Namboodiri AM
Glia; 2011 Oct; 59(10):1414-34. PubMed ID: 21598311
[TBL] [Abstract][Full Text] [Related]
8. Expression of aspartoacylase (ASPA) and Canavan disease.
Sommer A; Sass JO
Gene; 2012 Sep; 505(2):206-10. PubMed ID: 22750302
[TBL] [Abstract][Full Text] [Related]
9. Canavan disease and the role of N-acetylaspartate in myelin synthesis.
Namboodiri AM; Peethambaran A; Mathew R; Sambhu PA; Hershfield J; Moffett JR; Madhavarao CN
Mol Cell Endocrinol; 2006 Jun; 252(1-2):216-23. PubMed ID: 16647192
[TBL] [Abstract][Full Text] [Related]
10. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
Kaul R; Balamurugan K; Gao GP; Matalon R
Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
[TBL] [Abstract][Full Text] [Related]
11. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
[TBL] [Abstract][Full Text] [Related]
12. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B
J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190
[TBL] [Abstract][Full Text] [Related]
13. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system.
Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S
J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262
[TBL] [Abstract][Full Text] [Related]
14. Involvement of aspartoacylase in tremor expression in rats.
Nishitani A; Tanaka M; Shimizu S; Kunisawa N; Yokoe M; Yoshida Y; Suzuki T; Sakuma T; Yamamoto T; Kuwamura M; Takenaka S; Ohno Y; Kuramoto T
Exp Anim; 2016 Jul; 65(3):293-301. PubMed ID: 27026062
[TBL] [Abstract][Full Text] [Related]
15. Murine aspartoacylase: cloning, expression and comparison with the human enzyme.
Namboodiri MA; Corigliano-Murphy A; Jiang G; Rollag M; Provencio I
Brain Res Mol Brain Res; 2000 May; 77(2):285-9. PubMed ID: 10837925
[TBL] [Abstract][Full Text] [Related]
16. Bimodal occurrence of aspartoacylase in myelin and cytosol of brain.
Wang J; Matalon R; Bhatia G; Wu G; Li H; Liu T; Lu ZH; Ledeen RW
J Neurochem; 2007 Apr; 101(2):448-57. PubMed ID: 17254025
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the nuclear import pathways of galectin-3.
Nakahara S; Oka N; Wang Y; Hogan V; Inohara H; Raz A
Cancer Res; 2006 Oct; 66(20):9995-10006. PubMed ID: 17047062
[TBL] [Abstract][Full Text] [Related]
19. Nuclear trafficking of photoreceptor protein crx: the targeting sequence and pathologic implications.
Fei Y; Hughes TE
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2849-56. PubMed ID: 10967037
[TBL] [Abstract][Full Text] [Related]
20. Canavan disease: a white matter disorder.
Kumar S; Mattan NS; de Vellis J
Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
